MedTrace Logo

Qingdao Diabetes Prevention Project

NCT01053195 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 276793

Last updated 2016-08-29

No results posted yet for this study

Summary

Qingdao Diabetes Prevention Project aims to translate the trial experience to communities with specific objectives to:

* raise the public awareness of diabetes and diabetes risk factors
* promote healthy lifestyle of the entire targeting population
* reduce the number of people with obesity
* reduce the number of high-risk people developing diabetes through lifestyle intervention
* prevent the diabetic complications
* evaluate the effect and the cost of the community-based prevention project. The project is community-based targeting at the entire population of 1.94 million living in four administration districts of the city of Qingdao in China. In the first phase of the project (2005-2008) the work emphasis is on health promotion, training over 2000 primary care professionals and 300 school health nurses and establishing a network consisting of 600 community clinics. In the second phase (2008-2012) lifestyle counseling sessions will be provided to about 242112 high-risk individuals identified, and the efficacy and the cost of the project will be evaluated at the end of the project in 2012.

Conditions

Interventions

BEHAVIORAL

Lifestyle counseling

Non-diabetic high-risk subjects enrolled will be eligible for individual and/or group lifestyle counseling. The intervals of the counseling sessions depend on the glucose levels of the high-risk individuals, every three months for those having prediabetes and every six months for those with normal glucose levels but high risk score.

Sponsors & Collaborators

  • The World Diabetes Foundation

    collaborator OTHER

  • Qingdao Centers for Disease Control and Prevention

    collaborator OTHER_GOV

  • University of Helsinki

    lead OTHER

Principal Investigators

  • Qing Qiao, MD, PhD · Department of Public Health, University of Helsinki

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01053195 on ClinicalTrials.gov